发明名称 MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS
摘要 A formulation for drug delivery, providing enhanced modulation of solubility, stability, absorption, metabolism, and/or pharmacokinetic profile of a lipophilic therapeutic agent by formulation with sterols and/or sterol esters, resulting in higher bioavailability of a therapeutic agent administered to a subject in need of such therapeutic agent. The formulation contains a therapeutic agent and a sterol or sterol ester, and can, optionally, further contain a solubilizer and/or an enhancing agent. Also described are pharmaceutical compositions containing the formulations and methods of making and methods of using the formulations and pharmaceutical compositions. Formulations of the disclosure can be constituted to minimize the synthesis of dihydrotestosterone when the therapeutic agent includes testosterone or testosterone esters.
申请公布号 CA2822435(A1) 申请公布日期 2011.07.07
申请号 CA20102822435 申请日期 2010.12.31
申请人 DIFFERENTIAL DRUG DEVELOPMENT ASSOCIATES, LLC;SOV THERAPEUTICS 发明人 DHINGRA, OM
分类号 A61K9/48;A61K9/20;A61K9/22;A61K31/56;A61K31/575 主分类号 A61K9/48
代理机构 代理人
主权项
地址